A Phase 1/1b, Open Label, Dose Escalation and Expansion Study of SBT6050 in Patients with Advanced Solid Tumors Expressing HER2

  • Sabanathan, Dhanusha (Primary Chief Investigator)
  • Park, John (Associate Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)

Project: Research

Project Details

AcronymSBT6050-1001
StatusActive
Effective start/end date2/09/20 → 27/08/25